Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | MicrobiomeTrials

← Back to trials

NCT01875601

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

CompletedPHASE1INTERVENTIONAL

Trial Details

Start: 2013-06-11Est. Completion: 2015-09-08

Enrollment target: 16 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Other microbiome trials you might be interested in

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerPhase 2Recruiting

Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7

This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…

Mobile, United StatesEst. completion Nov 6, 2020

View Trial →

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyPhase 1Recruiting

Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm

Background: Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …

Bethesda, United StatesEst. completion Dec 31, 2029

View Trial →

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 3Recruiting

Non-small Cell Lung Cancer

This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participa…

Bakersfield, United StatesEst. completion Jan 24, 2028

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.